SETTING: A rural Zimbabwean hospital and the surrounding community. OBJECTIVES: To determine whether a particular haptoglobin phenotype is associated with increased susceptibility to clinical pulmonary tuberculosis, and to determine the outcome of treatment for pulmonary tuberculosis according to haptoglobin phenotype. DESIGN: A case-control study, and a prospective cohort study. RESULTS: We studied 98 consecutive patients with sputum-positive pulmonary tuberculosis and 98 sex- and age-matched controls. The haptoglobin (Hp) phenotype distributions did not differ significantly between the tuberculosis patients and controls (P = 0.5). During the 18-month follow-up period after the start of tuberculosis treatment, 6/18 (33%) cases with Hp 2-2 phenotype died compared to 9/47 (19%) with Hp 2-1 and 3/31 (10%) with Hp 1-1. In a logistic regression model, the odds of dying were 6.1-fold greater with Hp 2-2 than with Hp 1-1 (95%CI 1.04-35.1, P = 0.04). CONCLUSION: Our results suggest that there is equal susceptibility to clinical pulmonary tuberculosis disease amongst different haptoglobin phenotypes. Nonetheless, tuberculosis patients with Hp 2-2 phenotype had a higher risk of mortality.
SETTING: A rural Zimbabwean hospital and the surrounding community. OBJECTIVES: To determine whether a particular haptoglobin phenotype is associated with increased susceptibility to clinical pulmonary tuberculosis, and to determine the outcome of treatment for pulmonary tuberculosis according to haptoglobin phenotype. DESIGN: A case-control study, and a prospective cohort study. RESULTS: We studied 98 consecutive patients with sputum-positive pulmonary tuberculosis and 98 sex- and age-matched controls. The haptoglobin (Hp) phenotype distributions did not differ significantly between the tuberculosispatients and controls (P = 0.5). During the 18-month follow-up period after the start of tuberculosis treatment, 6/18 (33%) cases with Hp 2-2 phenotype died compared to 9/47 (19%) with Hp 2-1 and 3/31 (10%) with Hp 1-1. In a logistic regression model, the odds of dying were 6.1-fold greater with Hp 2-2 than with Hp 1-1 (95%CI 1.04-35.1, P = 0.04). CONCLUSION: Our results suggest that there is equal susceptibility to clinical pulmonary tuberculosis disease amongst different haptoglobin phenotypes. Nonetheless, tuberculosispatients with Hp 2-2 phenotype had a higher risk of mortality.
Authors: Vitor R R Mendonça; Nívea F Luz; Nadja J G Santos; Valéria M Borges; Marilda S Gonçalves; Bruno B Andrade; Manoel Barral-Netto Journal: Infect Immun Date: 2012-01-30 Impact factor: 3.441
Authors: Sarah H Atkinson; Tabitha W Mwangi; Sophie M Uyoga; Edna Ogada; Alex W Macharia; Kevin Marsh; Andrew M Prentice; Thomas N Williams Journal: Clin Infect Dis Date: 2007-02-07 Impact factor: 9.079
Authors: Simon Blankley; Christine M Graham; Joe Levin; Jacob Turner; Matthew P R Berry; Chloe I Bloom; Zhaohui Xu; Virgina Pascual; Jacques Banchereau; Damien Chaussabel; Ronan Breen; George Santis; Derek M Blankenship; Marc Lipman; Anne O'Garra Journal: Eur Respir J Date: 2016-04-13 Impact factor: 16.671
Authors: Marie-Christine W Gast; Harm van Tinteren; Marijke Bontenbal; René Q G C M van Hoesel; Marianne A Nooij; Sjoerd Rodenhuis; Paul N Span; Vivianne C G Tjan-Heijnen; Elisabeth G E de Vries; Nathan Harris; Jos W R Twisk; Jan H M Schellens; Jos H Beijnen Journal: BMC Cancer Date: 2008-12-24 Impact factor: 4.430
Authors: Joann M McDermid; Branwen J Hennig; Marianne van der Sande; Adrian V S Hill; Hilton C Whittle; Assan Jaye; Andrew M Prentice Journal: BMC Infect Dis Date: 2013-01-29 Impact factor: 3.090